Pharmacy college, Second Military Medical University, Shanghai, China.
Department of Chemistry, Shanghai University, Shanghai, China.
BMC Plant Biol. 2019 Aug 27;19(1):376. doi: 10.1186/s12870-019-1962-0.
As a traditional Chinese herb, safflower (Carthamus tinctorius L.) is valued for its florets to prevent cardiovascular and cerebrovascular diseases. Basing on previous chemical analysis, the main active compounds are flavonoids in its florets. Although flavonoid biosynthetic pathway has been well-documented in many model species, unique biosynthetic pathway remains to be explored in safflower. Of note, as an important class of transitional enzymes, chalcone isomerase (CHI) has not been characterized in safflower.
According to our previous research, CHIs were identified in a safflower transcriptome library built by our lab. To characterize CHI in safflower, a CHI gene named CtCHI1 was identified. A multiple sequences alignment and phylogenetic tree demonstrate that CtCHI1 shares 92% amino acid identity and close relationship with CHI to Saussurea medusa. Additionally, subcellular localization analysis indicated CtCHI1-GFP fusion protein was mainly in the cell nucleus. Further, we purified CtCHI1 protein from E. coli which can effectively catalyze isomerization of 2',4',4,6'-tetrahydroxychalcone into naringenin in vitro. Via genetic engineer technology, we successfully obtained transgenic tobacco and safflower lines. In transgenic tobacco, overexpression of CtCHI1 significantly inhibited main secondary metabolites accumulation, including quercetin (~ 79.63% for ovx-5 line) and anthocyanins (~ 64.55% for ovx-15 line). As shown in transgenic safflower, overexpression of CtCHI1 resulted in upstream genes CtPAL3 and CtC4H1 increasing dramatically (up to ~ 3.9fold) while Ct4CL3, CtF3H and CtDFR2 were inhibited. Also, comparing the whole metabolomics database by PCA and PLS-DA between transgenic and control group, 788 potential differential metabolites were marked and most of them displayed up-regulated trends. In parallel, some isolated secondary metabolites, such as hydroxysafflor yellow A (HSYA), rutin, kaempferol-3-O-β-rutinoside and dihydrokaempferol, accumulated in transgenic safflower plants.
In this study, we found that CtCHI1 is an active, functional, catalytic protein. Moreover, CtCHI1 can negatively and competitively regulate anthocyanins and quercetin pathway branches in tobacco. By contrast, CtCHI1 can positively regulate flavonol and chalcone metabolic flow in safflower. This research provides some clues to understand CHI's differential biochemical functional characterization involving in flavonoid pathway. More molecular mechanisms of CHI remain to be explored in the near future.
红花(Carthamus tinctorius L.)作为一种传统的中草药,以其花瓣预防心脑血管疾病而受到重视。基于之前的化学分析,其主要的活性化合物是花瓣中的类黄酮。尽管类黄酮的生物合成途径在许多模式物种中已经得到很好的描述,但红花中仍有待探索独特的生物合成途径。值得注意的是,作为一类重要的过渡酶,查尔酮异构酶(CHI)在红花中尚未被表征。
根据我们之前的研究,在我们实验室构建的红花转录组文库中鉴定出了 CHIs。为了表征红花中的 CHI,我们鉴定了一个名为 CtCHI1 的 CHI 基因。序列比对和系统发育树分析表明,CtCHI1 与 Saussurea medusa 的 CHI 具有 92%的氨基酸同一性和密切关系。此外,亚细胞定位分析表明,CtCHI1-GFP 融合蛋白主要位于细胞核内。进一步,我们从大肠杆菌中纯化了 CtCHI1 蛋白,该蛋白可有效催化 2',4',4,6'-四羟基查尔酮异构化为柚皮素体外。通过基因工程技术,我们成功获得了转基因烟草和红花株系。在转基因烟草中,CtCHI1 的过表达显著抑制了主要次生代谢物的积累,包括槲皮素(ovx-5 系约 79.63%)和花青素(ovx-15 系约 64.55%)。在转基因红花中,CtCHI1 的过表达导致 CtPAL3 和 CtC4H1 的上游基因显著增加(高达约 3.9 倍),而 Ct4CL3、CtF3H 和 CtDFR2 则受到抑制。此外,通过 PCA 和 PLS-DA 比较转基因和对照组的整个代谢组学数据库,标记了 788 个潜在差异代谢物,其中大多数呈上调趋势。同时,一些分离的次生代谢物,如羟基红花黄色 A(HSYA)、芦丁、山奈酚-3-O-β-芸香糖苷和二氢山奈酚,在转基因红花植株中积累。
本研究发现,CtCHI1 是一种具有活性、功能和催化活性的蛋白质。此外,CtCHI1 可以在烟草中负向和竞争性调节花青素和槲皮素途径分支。相反,CtCHI1 可以在红花中正向调节类黄酮醇和查尔酮的代谢流。本研究为理解 CHI 在涉及类黄酮途径的差异生化功能特征方面提供了一些线索。未来还需要进一步探索 CHI 的更多分子机制。